Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis
Original Article
O.V.D. Meeren, M. Hatherill, V. Nduba, R.J. Wilkinson, M. Muyoyeta, E.V. Brakel, H.M. Ayles, G. Henostroza, F. Thienemann, T.J. Scriba, A. Diacon, G.L. Blatner, M.-A. Demoitié, M. Tameris, M. Malahleha, J.C. Innes, E. Hellström, N. Martinson, T. Singh, E.J. Akite, A.K. Azam, A. Bollaerts, A.M. Ginsberg, T.G. Evans, P. Gillard, and D.R. Tait
N Engl J Med 2018;379:1621-1634
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course closed
This course closed on Sunday, October 25, 2020 - 11:59pm.